These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3942846)

  • 41. Recruitment of immature neutrophils in peripheral blood following leukocytapheresis therapy for rheumatoid arthritis.
    Okawa-Takatsuji M; Nagatani K; Nakajima K; Itoh K; Kano T; Nagashio C; Takahashi Y; Aotsuka S; Mimori A
    J Clin Apher; 2007; 22(6):323-9. PubMed ID: 18095302
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Factors that influence lymphocyte yields in lymphocytapheresis.
    Blanchette VS; McCombie NE; Rock G
    Transfusion; 1985; 25(3):242-5. PubMed ID: 4002308
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Two years serial lymphocytapheresis of progressive hyperleukocytosis in a patient with a non-Hodgkin's lymphoma.
    Heil B; Wüst T; Lang HR; Beeser HP; Arnold H
    Beitr Infusionsther; 1992; 30():306-10. PubMed ID: 1284722
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Filtration leukocytapheresis therapy in rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial.
    Hidaka T; Suzuki K; Matsuki Y; Takamizawa-Matsumoto M; Kataharada K; Ishizuka T; Kawakami M; Nakamura H
    Arthritis Rheum; 1999 Mar; 42(3):431-7. PubMed ID: 10088764
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Plasmapheresis and lymphoplasmapheresis in the management of rheumatoid arthritis.
    Wallace DJ; Goldfinger D; Gatti R; Lowe C; Fan P; Bluestone R; Klinenberg JR
    Arthritis Rheum; 1979 Jul; 22(7):703-10. PubMed ID: 454499
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Successful leukocytapheresis therapy in a patient with rheumatoid arthritis on maintenance hemodialysis.
    Maeshima K; Torigoe M; Iwakura M; Yamanaka K; Ishii K
    Mod Rheumatol; 2015 Jan; 25(1):154-7. PubMed ID: 24517518
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficient harvest of in vivo IL-2-activated CD3+ lymphocytes for adoptive immunotherapy by selective leukapheresis (lymphocytapheresis).
    Masucci G; Svensson A; Hansson M; Hansson J; Nakazawa T; Salazar F; Petersson M; Kiessling R
    J Hematother; 1997 Jun; 6(3):253-60. PubMed ID: 9234180
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Leukoplasmapheresis in severe rheumatoid arthritis].
    Ge MZ; Zhang XS; Xiong W
    Zhonghua Nei Ke Za Zhi; 1987 Feb; 26(2):80-2, 125. PubMed ID: 3608723
    [No Abstract]   [Full Text] [Related]  

  • 49. Intensive immunosuppression and autologous stem cell transplantation for patients with severe rheumatoid arthritis: the Leiden experience.
    van Laar JM; Verburg RJ; Fibbe WE; Breedveld FC
    J Rheumatol Suppl; 2001 Oct; 64():25-7. PubMed ID: 11642499
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Investigation of the clinical effect of large volume leukocytapheresis on methotrexate-resistant rheumatoid arthritis.
    Onuma S; Yamaji K; Kempe K; Ogasawara M; Ogawa T; Yang K; Kanai M; Tsuda H; Takasaki Y
    Ther Apher Dial; 2006 Oct; 10(5):404-11. PubMed ID: 17096694
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effect of thoracic duct drainage on lymphocyte dynamics and clinical symptoms in patients with rheumatoid arthritis.
    Ueo T; Tanaka S; Tominaga Y; Ogawa H; Sakurami T
    Arthritis Rheum; 1979 Dec; 22(12):1405-12. PubMed ID: 518724
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Calprotectin levels in patients with rheumatoid arthritis to assess and association with exercise treatment.
    Acar A; Guzel S; Sarifakioglu B; Guzel EC; Guzelant AY; Karadag C; Kiziler L
    Clin Rheumatol; 2016 Nov; 35(11):2685-2692. PubMed ID: 27094943
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Photopheresis for rheumatoid arthritis.
    Malawista SE; Trock D; Edelson RL
    Ann N Y Acad Sci; 1991 Dec; 636():217-26. PubMed ID: 1793211
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A randomised, blinded, placebo-controlled, dose escalation study of the tolerability and efficacy of filgrastim for haemopoietic stem cell mobilisation in patients with severe active rheumatoid arthritis.
    Snowden JA; Biggs JC; Milliken ST; Fuller A; Staniforth D; Passuello F; Renwick J; Brooks PM
    Bone Marrow Transplant; 1998 Dec; 22(11):1035-41. PubMed ID: 9877264
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Extracorporeal therapy of rheumatoid arthritis].
    Aseeva EA; Solov'ev SK; Chiklikchi AS
    Ter Arkh; 2001; 73(6):70-5. PubMed ID: 11521529
    [No Abstract]   [Full Text] [Related]  

  • 56. Identification of known and novel genes in activated monocytes from patients with rheumatoid arthritis.
    Stuhlmüller B; Ungethüm U; Scholze S; Martinez L; Backhaus M; Kraetsch HG; Kinne RW; Burmester GR
    Arthritis Rheum; 2000 Apr; 43(4):775-90. PubMed ID: 10765922
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Leukocytapheresis and rheumatoid arthritis: comment on the article by Hidaka et al.
    Wallace DJ
    Arthritis Rheum; 1999 Oct; 42(10):2255-6. PubMed ID: 10524704
    [No Abstract]   [Full Text] [Related]  

  • 58. Rheumatoid arthritis associated with expanded populations of granular lymphocytes.
    Barton JC; Prasthofer EF; Egan ML; Heck LW; Koopman WJ; Grossi CE
    Ann Intern Med; 1986 Mar; 104(3):314-23. PubMed ID: 3946976
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lymphapheresis and radiation therapy for rheumatoid arthritis (RA).
    Bunch TW
    Minn Med; 1984 Jul; 67(7):385-6. PubMed ID: 6472240
    [No Abstract]   [Full Text] [Related]  

  • 60. Human T-lymphotropic virus type I associated myelopathy treated effectively with lymphocytapheresis using a leukocyte removal filter.
    Oishi M; Mochizuki Y; Hara M; Uryu H; Osaka S; Maejima M; Sawada S; Takasu T
    Intern Med; 1995 Dec; 34(12):1215-9. PubMed ID: 8929654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.